Assessment of factors associated with dose differences between Japan and the United States.


Although it is well known that there are differences in approved doses between Japan and the United States, there has been no comprehensive research into the causes thereof. This study furthers the discussion of our previous investigation in 2010, with particular focus on pharmaceutical industry strategy and regulatory policy, among drugs approved in Japan… (More)
DOI: 10.1038/clpt.2013.231


4 Figures and Tables